Stephanie Wic Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13941 Springview Ln, Orland Park, IL 60467 Phone: 708-699-8152 |
Miss Lindsay Mitacek Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16170 S. Kingsport Road, Orland Park, IL 60467 Phone: 708-326-1550 |
Ms. Kerry Eileen Mallen Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14601 John Humphrey Dr, Orland Park, IL 60462 Phone: 708-349-8300 |
Mrs. Menissa Hirshberg, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16170 Kingsport Rd, Orland Park, IL 60467 Phone: 708-349-6544 |
Shadia Ramadan, MHS-CCC/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9317 W. 142nd St, Orland Park, IL 60462 Phone: 708-275-9618 |
Sarah Mullens, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16170 Kingsport Rd, Orland Park, IL 60467 Phone: 708-349-6544 |
Niveen M Atieh, M.H.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14711 S Ravinia Ave, Orland Park, IL 60462 Phone: 708-226-9200 |
Denise A Ellis Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15021 Hale Dr, Orland Park, IL 60462 Phone: 708-289-8759 |
Sylvia M. Egan, M.S.,CCC Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 14601john Humphrey Drive, Orland Park, IL 60462 Phone: 708-349-8300 Fax: 708-460-5136 |
Marzieh Saffarian, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16170 Kingsport Rd, Orland Park, IL 60467 Phone: 989-906-1725 |
Arely Solis Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14225 S 95th Ave, Orland Park, IL 60462 Phone: 708-787-0952 Fax: 708-787-0958 |
Emily Sinnard, MS SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16170 Kingsport Rd, Orland Park, IL 60467 Phone: 708-326-1550 |
Natasha Przybylo, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14601 John Humphrey Dr, Orland Park, IL 60462 Phone: 708-349-8300 |
Stephanie Anderson, MS CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14101 Creek Crossing Dr, Orland Park, IL 60467 Phone: 708-364-3444 |
Mary Elizabeth Huizinga, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14711 S Ravinia Ave, Orland Park, IL 60462 Phone: 815-469-1500 |
Kelly Vitiritti, SLP/CFY Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16170 S. Kingsport Rd., Orland Park, IL 60467 Phone: 708-326-1550 Fax: 708-326-1557 |
Lidia Zacharczuk Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15524 Canterbury Ln, Orland Park, IL 60462 Phone: 708-745-0926 |
Erica Chin Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14601 John Humphrey Dr, Orland Park, IL 60462 Phone: 708-349-8300 |
Mary Kathryn Warchol, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16170 Kingsport Rd, Orland Park, IL 60467 Phone: 708-214-5878 |
Susan Schaedel Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15417 Pembridge Rd, Orland Park, IL 60462 Phone: 708-743-5258 |
News Archive
Researchers employ a structure-guided approach for the development of a series of ACE2-Fc variants using human IgG1 or IgG3 backbone.
The study carried out by researchers from the Centre for Plant Biotechnology and Genomics along with the Allergy Department of the Hospital Infantil Universitario Niño Jesús of Madrid have shown that, most of the children that received this new oral immunotherapy treatment were able to eat 100 grams of wheat bread without side effects. This result has overcome the risk of accidental ingestion by patients with this allergy. This research could be the basis for large clinical trials with more patients with the aim of assessing the therapeutic benefit of this new approach.
Cyterix Pharmaceutics, Inc. announced today that the company has raised $9.2 million in a Series A financing from The Column Group and SV Life Sciences. Cyterix is developing novel cancer therapeutics based on a prodrug approach that targets extra-hepatic cytochrome P450 enzymes that are over-expressed in many cancers to a high frequency, but not in normal tissues.
Gamma Medica, developer of advanced digital molecular imaging technologies for the detection of breast cancer, is pleased to announce a new strategic partnership with Volpara Solutions, leaders in the development of quantitative breast imaging tools. By using these technologies in parallel, physicians can implement screening protocols based on a woman's breast density and individual risk factors.
› Verified 2 days ago